Simplify Logo

Full-Time

Clinical Account Manager-Michigan

Posted on 5/23/2024

Ceribell

Ceribell

201-500 employees

EEG devices for monitoring brain activity

Hardware
Biotechnology
Healthcare

Compensation Overview

$100k - $180kAnnually

+ Commission + Equity

Mid, Senior

Michigan, USA

Category
Customer Success Management
Sales & Account Management
Required Skills
Sales
Requirements
  • 3-5 years of recent critical care sales experience OR 5 years and med device or pharma experience OR RN’s with industry experience in supporting sales teams.
  • Experience working with multiple key stakeholders (physicians, management, administration) or hospital-wide committee membership.
  • Excellent Communicator, Relationship Builder, Creative & Effective Problem Solver, highly organized and ability to prioritize strategically.
  • Ability to accurately assess and understand different stakeholders needs/wants. Process cross functional agendas and adjust strategy to achieve desired outcomes.
  • Confidence and expertise required to effectively challenge the status quo and influence meaningful change through consensus building
  • Driven & Coachable: innate desire to succeed; willing to seek out coaching, accept feedback and apply new skills supports measurable change
  • Grit, high integrity
  • Bonus points: start-up experience or experience working with disruptive technology, med device experience, neuro ICU clinical experience, sales experience.
Responsibilities
  • Driving New and Organic Growth
  • Clinical Training / Education
  • Reporting and Administration

Ceribell focuses on developing medical devices that utilize electroencephalogram (EEG) technology to monitor brain activity. Their main product, the Ceribell EEG Headband and Recorder, is designed for use by trained healthcare providers in professional settings. These devices help gather important data about a patient's brain activity, which healthcare professionals can analyze to make informed treatment decisions. Unlike some other EEG devices, Ceribell's products do not provide diagnostic conclusions or automated alerts; instead, they serve as a tool for data collection, particularly in urgent situations like Nonconvulsive Status Epilepticus (NCSE), where timely intervention is crucial. Ceribell differentiates itself by focusing on the speed and efficiency of data gathering, which is vital in critical care scenarios. The company's goal is to enhance the ability of healthcare providers to monitor and respond to neurological conditions effectively.

Company Stage

Series C

Total Funding

$172M

Headquarters

Mountain View, California

Founded

2014

Growth & Insights
Headcount

6 month growth

8%

1 year growth

23%

2 year growth

76%
Simplify Jobs

Simplify's Take

What believers are saying

  • Ceribell's recent $102 million equity investment and $50 million financing round indicate strong financial backing for expansion and product development.
  • The appointment of experienced leaders like Sean Manni and Joshua Copp positions the company for strategic growth and operational excellence.
  • Recognition by Fast Company as one of the World's Most Innovative Companies highlights Ceribell's industry impact and potential for continued innovation.

What critics are saying

  • The reliance on healthcare providers to interpret EEG data may limit the device's adoption in settings with less specialized staff.
  • The competitive landscape in medical devices and AI-powered diagnostics could pose challenges to Ceribell's market share.

What makes Ceribell unique

  • Ceribell's AI-powered point-of-care EEG system is a first-of-its-kind technology, setting it apart from traditional EEG devices.
  • The company's focus on rapid, easy-to-use brain monitoring solutions for time-critical conditions like NCSE provides a unique value proposition.
  • FDA Breakthrough Device Designation for delirium detection further validates Ceribell's innovative approach in neurodiagnostics.
INACTIVE